Smartphone app could spot deadly skin cancer in rare disease patients

NCT ID NCT05843994

First seen Feb 03, 2026 · Last updated May 15, 2026 · Updated 12 times

Summary

This study is creating an artificial intelligence (AI) app that can spot a type of skin cancer called squamous cell carcinoma (SCC) in people with recessive dystrophic epidermolysis bullosa (RDEB), a rare blistering condition. SCC is the leading cause of death in adults with RDEB, and catching it early makes treatment easier. The app will analyze photos taken by patients at home to help detect cancer sooner. About 20 participants with RDEB and a history of SCC will submit their photos to train and test the AI.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPIDERMOLYSIS BULLOSA DYSTROPHICA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Department of Dermatology, Northwestern University Feinberg School of Medicine and Lurie Children's Hospital

    Chicago, Illinois, 60611, United States

Conditions

Explore the condition pages connected to this study.